These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21986775)

  • 1. Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension.
    Nazer B; Humphreys BD; Moslehi J
    Circulation; 2011 Oct; 124(15):1687-91. PubMed ID: 21986775
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab: overview of the literature.
    Braghiroli MI; Sabbaga J; Hoff PM
    Expert Rev Anticancer Ther; 2012 May; 12(5):567-80. PubMed ID: 22594892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension associated with angiogoenesis inhibitors: what do oncologists really do in daily routine? A small survey.
    Dişel U; Abalı H; Sümbül AT; Ozyılkan O
    J Clin Hypertens (Greenwich); 2011 Nov; 13(11):863. PubMed ID: 22051434
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac testing to manage cardiovascular risk in cancer patients.
    Davis M; Witteles RM
    Semin Oncol; 2013 Apr; 40(2):147-55. PubMed ID: 23540740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer.
    Stefanadis C; Synetos A; Tousoulis D; Tsiamis E; Michelongona A; Zagouri F; Bamias A; Dimopoulos MA; Kyvelou S; Kapelakis I; Toutouzas K
    Int J Cardiol; 2012 Feb; 154(3):341-4. PubMed ID: 22078988
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.
    Lombardi G; Zustovich F; Farina P; Fiduccia P; Della Puppa A; Polo V; Bertorelle R; Gardiman MP; Banzato A; Ciccarino P; Denaro L; Zagonel V
    Anticancer Drugs; 2013 Jan; 24(1):90-7. PubMed ID: 23075631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer.
    Zhou Y; Zhang Y; Yang X; Fan L; Jiang J
    Breast J; 2012 Sep; 18(5):502-3. PubMed ID: 22891618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiogenesis inhibitor therapies: focus on hypertension and kidney toxicity].
    Izzedine H
    Bull Cancer; 2007 Nov; 94(11):981-6. PubMed ID: 18055316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab recommendation highlights difficulties.
    Printz C
    Cancer; 2011 Nov; 117(22):5025. PubMed ID: 22052367
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA panel votes to pull Avastin in breast cancer, again.
    Ratner M
    Nat Biotechnol; 2011 Aug; 29(8):676. PubMed ID: 21822226
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac complications and manifestations of chemotherapy for cancer.
    Khawaja MZ; Cafferkey C; Rajani R; Redwood S; Cunningham D
    Heart; 2014 Jul; 100(14):1133-40. PubMed ID: 24326899
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of circulating heparin in cancer patients after port flush of indwelling venous access devices: implications for bevacizumab-associated thrombosis.
    Amirkhosravi A; Meyer T; Hatfield M; Desai H; Amaya M; Drexler A; Reyes E; Barranco J; Rathmann K; Bigsby G; Francis JL
    Blood Coagul Fibrinolysis; 2012 Mar; 23(2):176-7. PubMed ID: 22270797
    [No Abstract]   [Full Text] [Related]  

  • 13. Is Avastin the right choice of treatment for retinopathy of prematurity?
    Käll A
    Acta Paediatr; 2012 Aug; 101(8):796-8. PubMed ID: 22788788
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting cardiovascular complications.
    Mayor S
    Lancet Oncol; 2006 Apr; 7(4):282. PubMed ID: 16598871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generation mechanisms and management strategies of adverse reactions to Bevacizumab during cancer treatment].
    Ge FJ; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):481-6. PubMed ID: 21029688
    [No Abstract]   [Full Text] [Related]  

  • 16. Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
    Mir O; Mouthon L; Alexandre J; Mallion JM; Deray G; Guillevin L; Goldwasser F
    J Natl Cancer Inst; 2007 Jan; 99(1):85-6. PubMed ID: 17202119
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bevacizumab. Progress in cancer therapy by antiangiogenesis].
    Krämer I; Lipp HP
    Med Monatsschr Pharm; 2006 Jul; 29(7):249-54; quiz 255-6. PubMed ID: 16866078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic treatment in age-related macular degeneration in patients with a history of cerebrovascular risk.
    García-López L; Coloma Peral R; Criado Illana MT
    Farm Hosp; 2012; 36(3):169-70. PubMed ID: 22115858
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab-induced bowel perforation.
    Sliesoraitis S; Tawfik B
    J Am Osteopath Assoc; 2011 Jul; 111(7):437-41. PubMed ID: 21803880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avastin for breast cancer, 2005-2011: requiescat in pacem?
    Burstein HJ
    J Natl Compr Canc Netw; 2011 Dec; 9(12):1321-3. PubMed ID: 22157551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.